Search results for ☢ Che
-
Business Wire
Checkmate Pharmaceuticals Announces CEO Transition and $22 Million Financing
December 12, 2018 -
Checkmate Pharmaceuticals Announces Strategic Collaboration with Merck KGaA, Darmstadt, Germany and Pfizer to Evaluate Combination Therapy with CMP-001 and Avelumab
September 5, 2018 -
Checkmate Pharmaceuticals Presents Clinical Data at the 2018 American Association for Cancer Research (AACR) Annual Meeting
April 17, 2018 -
Checkmate Pharmaceuticals Announces Start of Phase 1b Trial of CMP-001 in Combination with Anti-PD-L1 Immunotherapy in Anti-PD-1/PD-L1 Resistant Advanced Non-Small Cell Lung Cancer
April 24, 2018 -
Checkmate Pharmaceuticals to Present Data at the 2018 American Association for Cancer Research (AACR) Annual Meeting
March 28, 2018 -
Cipla ties up with Roche to sell 2 cancer drugs in India
February 28, 2018 -
Froedtert Provides Patients with Symptom Checker from Boston Startup Buoy Health
March 9, 2018 -
TraceLink, Roche and SPI Win GS1 Brazil Automation Award for RDC 54 Compliance Pilot
November 24, 2015 -
Biodesix Announces Biomarker Research Collaboration with Checkmate Pharmaceuticals
March 20, 2018 -
PR Newswire
Insilico Medicine and ChemDiv form a strategic drug discovery service alliance
October 16, 2019 -
BioSpace
Checkmate Pharmaceuticals Announces Additions to Management Team
October 15, 2019 -
PR Newswire
First Patient Dosed in Sintilimab and Anti-VEGF Monoclonal Antibody IBI305 with Chemotherapy in Patients with EGFR-mutant Non-squamous NSCLC who have Progressed from Prior EGFR-TKI Treatment
July 24, 2019 -
PR Newswire
Comanche Biopharma Announces FDA Clearance of Investigational New Drug (IND) Application for CBP-4888, an siRNA Investigational Therapy for the Treatment of Preeclampsia
March 30, 2023 -
PR Newswire
Comanche Biopharma Announces Appointment of Allison August, M.D., as Chief Medical Officer
December 15, 2022 -
PR Newswire
Comanche Biopharma Receives US FDA Fast Track Designation for CBP-4888 for the Treatment of sFlt-1 mediated pre-term preeclampsia
August 23, 2023 -
PR Newswire
Comanche Biopharma Named by Fierce Biotech as a “Fierce 15” Biotech Company of 2023
August 28, 2023 -
GlobeNewswire
Tempest Announces First Patient Dosed in Randomized Study Evaluating TPST-1120 in First-Line Regimen for Hepatocellular Carcinoma in Clinical Collaboration with Roche
September 20, 2021 -
Endpoints News
F-Prime backs a niche AI software startup hunting lofty goals in $22M Series B
February 4, 2020 -
Business Wire
Checkmate Pharmaceuticals Granted FDA Fast Track Designation for CMP-001 Combined with PD-1 Blockade in the Treatment of Certain Types of Metastatic or Unresectable Melanoma
July 27, 2020 -
PR Newswire
Innovent and Lilly Jointly Announce the Approval of TYVYT® (sintilimab injection) by China NMPA in Combination with Pemetrexed and Platinum Chemotherapy as First-Line Therapy for Nonsquamous Non-Small Cell Lung Cancer
February 2, 2021 -
PR Newswire
Innovent Releases Interim Analysis Results of Sintilimab in Combination with Chemotherapy for the First-Line Treatment of Advanced or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma in the Phase 3 ORIENT-16 Study at ESMO Congress 2021
September 17, 2021 -
Business Wire
X-Chem and Sironax Begin Neurodegenerative Disease Drug Discovery Research Partnership
January 5, 2023 -
Business Wire
Checkmate Pharmaceuticals Announces Appointment of Kleem Chaudhary as Chief Business Officer
October 31, 2019 -
TheStreet
IPO Launch: Checkmate Pharmaceuticals Proposes $75 Million IPO
August 4, 2020 -
PR Newswire
Tyvyt® (Sintilimab Injection) Combined with Gemzar® (Gemcitabine for Injection) and Platinum Chemotherapy Met the Predefined Primary Endpoint in the Phase 3 ORIENT-12 Study as First-Line Therapy in Patients with Locally Advanced or Metastatic Squamous Non-Small Cell Lung Cancer
May 6, 2020 -
GlobeNewswire
Checkmate Pharmaceuticals Announces Pricing of Initial Public Offering
August 7, 2020 -
PR Newswire
Innovent and Lilly Release Clinical Trial Results of Sintilimab in Combination with ALIMTA® (Pemetrexed) and Platinum Chemotherapy as First-Line Treatment for Nonsquamous NSCLC in an Oral Presentation at IASLC WCLC 2020 Virtual Presidential Symposium
August 8, 2020 -
BioSpace
Checkmate Pharmaceuticals Presents Positive Clinical Data with CMP-001 at The 34th Annual Meeting of The Society for Immunotherapy of Cancer (SITC)
November 5, 2019 -
PR Newswire
Comanche Biopharma Appoints Allyson Felix to Board of Directors
May 12, 2023 -
PR Newswire
Buoy Health Selected as Preferred Partner in AI Enhanced Symptom Checker/ Digital Front Door Category by Consortium Health Plans
August 17, 2020 -
GlobeNewswire
Arvelle Announces Closing of Final Tranche of Series A Financing Round
May 26, 2020 -
PR Newswire
Regeneron to Acquire Checkmate Pharmaceuticals and Its Investigational Immune Activator for Potential Use in Multiple Tumor Types
April 19, 2022 -
Endpoints News
Comanche secures $75M to test preeclampsia siRNA in PhII, adds Scott Gottlieb to board
January 17, 2024 -
GlobeNewswire
Checkmate Pharmaceuticals Announces Clinical Collaboration with Bristol Myers Squibb to Evaluate CMP-001 in Combination with Nivolumab
December 8, 2020 -
GlobeNewswire
Checkmate Pharmaceuticals Announces Initiation of Patient Dosing in Potential Registration Trial of Vidutolimod (CMP-001) in Patients with Anti-PD-1 Refractory Advanced Melanoma
May 4, 2021 -
GlobeNewswire
Tempest Therapeutics Announces Clinical Collaboration with Roche to Advance TPST-1120 into a Randomized Combination Study in First-line Hepatocellular Carcinoma
March 3, 2021 -
PR Newswire
Insilico Medicine Successfully Explores the Advantages of Quantum Generative Adversarial Networks in Generative Chemistry
May 17, 2023 -
Endpoints News
Comanche lines up trial for preeclampsia siRNA with Moderna, Medicines Company vets and GV backing
May 19, 2023 -
GlobeNewswire
Checkmate Pharmaceuticals Announces Clinical Supply Agreement with Regeneron to Evaluate Vidutolimod (CMP-001) in Combination with Libtayo® (cemiplimab)
May 10, 2021 -
PR Newswire
Innovent Provides Update on Phase Ib Study of Sintilimab in Combination with Chemotherapy for First-line Advanced or Metastatic Non-small Cell Lung Cancer
May 30, 2019 -
PR Newswire
Innovent and Roche Enter into A Strategic Collaboration to Discover and Develop Multiple Products including Cellular Therapies and Bispecific Antibodies
June 9, 2020 -
PR Newswire
Insilico Medicine Appoints Business Leader, Michelle Chen, as Chief Business Officer
October 19, 2021 -
Business Wire
Checkmate Pharmaceuticals Secures $85 Million in Series C Financing
June 10, 2020 -
MIT Technology Review
These fast, cheap tests could help us coexist with covid
April 27, 2022 -
PR Newswire
U.S. FDA Accepts Regulatory Submission for Sintilimab in Combination with Pemetrexed and Platinum Chemotherapy for the First-Line Treatment of People with Nonsquamous Non-Small Cell Lung Cancer
May 18, 2021 -
Fierce Pharma
Bayer, Hua Medicine snag first-in-class nod in China for Roche castoff diabetes drug, but commercial value uncertain
October 10, 2022 -
Business Wire
Checkmate Pharmaceuticals Announces Dosing of First Patient in a Phase 1b/2 Study in Squamous Cell Carcinoma of the Head and Neck with Lead Investigational Candidate CMP-001
October 1, 2019 -
PR Newswire
Innovent Announces Sintilimab in Combination with Chemotherapy Meets the Primary Endpoint of Overall Survival in the Phase 3 ORIENT-16 Study for the First-Line Treatment of Advanced or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma
August 15, 2021 -
PR Newswire
Innovent and Lilly Jointly Release Phase 3 Results of TYVYT® (Sintilimab Injection) in Combination with GEMZAR® (Gemcitabine) and Platinum Chemotherapy as First-Line Treatment for Squamous Non-Small Cell Lung Cancer at ESMO Virtual Congress 2020
September 21, 2020 -
GlobeNewswire
Junshi and Coherus Biosciences Announce Positive Interim Results of CHOICE-01, a Phase 3 Clinical Trial Evaluating Toripalimab in Combination with Chemotherapy as First-Line Treatment for Non-Small Cell Lung Cancer
August 18, 2021 -
Business Wire
Caribou Biosciences Co-Founder Dr. Jennifer Doudna Awarded Nobel Prize in Chemistry
October 7, 2020 -
The Motley Fool
Blueprint Medicines Inks Deal With Roche Worth Up to $1.7 Billion
July 14, 2020 -
PR Newswire
Comanche Biopharma Strengthens Board of Directors with Appointment of Dr. Ann Taylor
June 13, 2023 -
GlobeNewswire
Coherus and Junshi Biosciences to Present Positive Progression Free Survival and Overall Survival Results from JUPITER-06, a Phase 3 Clinical Trial Evaluating Toripalimab in Combination with Chemotherapy as First-Line Treatment for Advanced Esophageal Squamous Cell Carcinoma
September 16, 2021 -
Business Wire
Innovusion Announces Its High-Resolution Image-Grade LiDAR System “Cheetah”, Enabling the Safest Performance in the Vehicle Mobility Industry
June 14, 2019 -
Eywa Pharma announces $30M investment from Eight Roads Ventures, F-Prime Capital and Envestor Ventures
October 18, 2016 -
Turnstone Biologics Announces U.S. FDA Acceptance of IND for Immunotherapy Targeting HPV Positive Cancers
May 16, 2018 -
Business Wire
Innovusion Raises US $30M in Series A Round and Starts Shipping the World’s First Image-Grade LiDAR System for Autonomous Vehicles
October 25, 2018 -
Globe Newswire
Flywire Makes Cross-Border Payments from India Easier
October 16, 2018 -
Beam Therapeutics Launched to Develop Harvard Base Editing Technology toward Precision Genetic Medicines
May 14, 2018 -
GlobeNewswire
GeneTx and Ultragenyx Announce First Patient Dosed in Phase 1/2 Clinical Trial of GTX-102 in Patients with Angelman Syndrome
March 16, 2020 -
WuXi PharmaTech Launches Medical Device Testing Services in China
October 23, 2015 -
Tempest Therapeutics Reports Proof of Mechanism Data for First-in-Class PPAR Alpha Antagonist
November 13, 2018 -
Vestwell Partners with Fiserv for 401k Robo Services
July 11, 2017 -
Cygnus super specialty hospital first to introduce Gastroenterology unit in Kaithal
January 21, 2018 -
Unum Therapeutics Announces Recombinant DNA Advisory Committee’s (RAC) Unanimous Approval of Phase 1 Study Protocol to Evaluate ACTR Cell Therapy in Non-Hodgkin Lymphoma
December 14, 2015 -
Fidelity Biosciences Leads Investment Into Avidity Nanomedicines
October 7, 2014 -
Hua Medicine Raises $117.4 Million in Series D & Series E Financing
March 27, 2018 -
Trivitron patents NeoMass AAAC kit for newborn screening to detect 50 inborn disorders
January 12, 2016 -
Innovent doses first patient in Phase III sintilimab trial for NSCLC
September 13, 2018